Fu Caixuan, Chu Jianfeng, Shen Aling, Liu Liya, Chen Hongwei, Lin Jiumao, Sferra Thomas J, Chen Youqin, Peng Jun
Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, P.R. China.
Fujian Key Laboratory of Integrative Medicine on Geriatrics, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, P.R. China.
Exp Ther Med. 2017 Sep;14(3):2291-2297. doi: 10.3892/etm.2017.4755. Epub 2017 Jul 10.
Chemotherapeutic agents, including 5-fluorouracil (5-FU), frequently cause intestinal mucositis as a side effect, leading to life quality reduction in colorectal cancer (CRC) patients and interruption of CRC treatment. Traditional Chinese medicines (TCMs) have recently received attention due to their relatively few adverse effects. Pien Tze Huang (PZH), a well-known TCM formulation first documented to have been prescribed >450 years ago, has been demonstrated to be clinically effective in treating various types of cancer including CRC. Although previous studies by our group reported that PZH possesses a variety of anti-cancer activities via multiple mechanisms, it has remained elusive whether it is able to reduce intestinal mucositis induced by 5-FU. The present study evaluated the effect of PZH on 5-FU-induced intestinal mucositis in CT-26 tumor-bearing xenograft mice and investigated the possible molecular mechanism. The results indicated that administration of PZH effectively alleviated the severity of 5-FU-induced diarrhea and morphological intestinal damages, but had no significant effect on body weight loss. In addition, a terminal deoxynucleotidyl transferase dUTP nick end labeling assay revealed that PZH treatment significantly inhibited cell apoptosis in the intestinal crypt. Furthermore, immunohistochemical staining showed that PZH treatment reduced the protein expression of pro-apoptotic B-cell lymphoma 2 (Bcl-2)-associated X protein but enhanced that of anti-apoptotic Bcl-2 in the intestinal crypt. Taken together, the results of the present study suggested that PZH effectively attenuates 5-FU-induced intestinal mucositis, which is in part associated with its inhibitory effect on cell apoptosis in the intestinal crypt.
化疗药物,包括5-氟尿嘧啶(5-FU),经常会引起肠道粘膜炎作为副作用,导致结直肠癌(CRC)患者生活质量下降以及CRC治疗中断。中药(TCMs)由于其相对较少的副作用最近受到了关注。片仔癀(PZH),一种最早记载于450多年前的著名中药配方,已被证明在治疗包括CRC在内的各种类型癌症方面具有临床疗效。尽管我们小组之前的研究报告称PZH通过多种机制具有多种抗癌活性,但它是否能够减轻5-FU诱导的肠道粘膜炎仍不清楚。本研究评估了PZH对CT-26荷瘤异种移植小鼠中5-FU诱导的肠道粘膜炎的影响,并研究了可能的分子机制。结果表明,给予PZH可有效减轻5-FU诱导的腹泻严重程度和肠道形态损伤,但对体重减轻没有显著影响。此外,末端脱氧核苷酸转移酶dUTP缺口末端标记试验显示,PZH治疗可显著抑制肠道隐窝中的细胞凋亡。此外,免疫组织化学染色显示,PZH治疗可降低肠道隐窝中促凋亡的B细胞淋巴瘤2(Bcl-2)相关X蛋白的蛋白表达,但增强抗凋亡的Bcl-2的蛋白表达。综上所述,本研究结果表明PZH可有效减轻5-FU诱导的肠道粘膜炎,这部分与其对肠道隐窝细胞凋亡的抑制作用有关。